Enhanced Targeting and Immune Activation of Tumor Microenvironment by Nanomodified Anti-PD1 in Liver Cancer

Ou, DL; Tseng, SJ; Kempson, IM; Hsu, CL; Yang, PC; Liao, ZX

Liao, ZX (corresponding author), Natl Taiwan Univ, Grad Inst Oncol, Coll Med, Taipei 10051, Taiwan.; Liao, ZX (corresponding author), Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 80424, Taiwan.

ADVANCED THERAPEUTICS, 2021; 4 (6):

Abstract

Liver cancer is one of the most common cancers worldwide, 75% of which are hepatocellular carcinoma (HCC). Generally, chronic inflammation and an immu......

Full Text Link